Die Rolle von Signal Transducer and Activator of Transcription 5 (Stat5) und dem Glukokortikoidrezeptor (GR) in der Hepatozytenfunktion
Year: 2008
Type: dissertation
Abstract: Signal transducer and activator of transcription 5 (Stat5) represents a cytokine- and growth factor-dependent transcription factor regulating important biological processes such as postnatal body growth, erythropoiesis and the expression of milk protein genes. The glucocorticoid receptor (GR) binds Stat5 in a cofactor fashion and was reported to modulate Stat5 target gene specificity. In this study we aimed to elucidate the role of Stat5 in pivotal hepatocyte processes such as the regulation of postnatal body growth, fatty acid metabolism and liver fibrogenesis, taking into account its propensity to interact with the GR. The major findings of this study are summarized in the following: (i) Hepatic loss of Stat5, the GR or both resulted in comparable defects in postnatal body growth. This was accompanied by quantitatively similar changes in transcription profiles, affecting predominantly growth-related Stat5 target genes (e.g. IGF-1 and Socs2). These observation suggested the existence of a linear Stat5-GR signal transduction pathway essential for regulating postnatal body growth. Using protein interaction studies the Stat5 aminoterminus was identified as docking platform for the GR. Luciferase reporter assays confirmed the Stat5-GR-dependent synergism in vitro exemplarily for transactivation of the Socs2 promoter. (ii) Hepatic loss of Stat5 in mice leads to the pathological accumulation of lipids in hepatocytes (steatosis). This coincides with perturbations of hepatic lipid metabolism such as hepatic insulin resistance and induction of de novo lipogenesis mediated by lipogenic master regulators PPARgamma and SREBP-1c. Compound loss of Stat5 and GR in hepatocytes severely aggravates this phenotype, leading to late-stage hepatopathologies such as severe steatosis and liver fibrosis already in young animals. At older ages, these mutants additionally exhibit depletions of peripheral fat stores (lipodystrophy) leading to an increased lipid flux into hepatic tissues and thus exacerbating disease. The two-step pathogenesis observed in double knockout animals closely mimics the onset and progression of human nonalcoholic fatty liver disease (NAFLD). (iii) Hepatic loss of Stat5 in a murine model for proinflammatory liver carcinogenesis (MDR2- model) leads to extrahepatic cholestasis (bile duct obstruction) causing secondary liver fibrosis at young ages. The pathogenesis in these animals comprises major hallmarks observed in fibrotic states such as the activation of hepatic stellate cells and remodelling of the extracellular matrix. Ablation of Stat5 in hepatocytes leads to a direct loss of Stat5-dependent basolateral bile acid transporter transcription in hepatocytes and thus coincides with perturbations in hepatic bile acid circulation and recycling. This may eventually cause hepatocyte damage and, finally, liver fibrosis and cirrhosis. Taken together, two published first-author manuscripts and one first-author manuscript in preparation resulted from this (see section 8).
Author: Kornfeld, Jan-Wilhelm
Institution: Christian-Albrechts-Universität zu Kiel
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: STAT5, glucocorticoid receptor, hepatocyte function, fatty acid metabolism, liver fibrosis, hepatic steatosis, insulin resistance, de novo lipogenesis, PPARγ, SREBP-1c, lipodystrophy, non-alcoholic fatty liver disease, cholestasis, hepatocarcinogenesis, MDR2, liver regeneration, insulin-like growth factor I, SOCS2
Open Access status: green
OpenAlex ID: W7110492226
